Top 2 Health Care Stocks That May Keep You Up At Night This Month
1. Taysha Gene Therapies received FDA's Breakthrough Therapy designation for TSHA-102. 2. Taysha's stock increased 12% in the last month, closing at $3.18. 3. Nanobiotix reported significantly improved losses, with shares rising 122% recently. 4. Both stocks exhibit overbought conditions according to their RSI values. 5. Healthcare sector momentum may imply broader S&P 500 impacts.